Hiromichi Kimura

Hiromichi Kimura is the founder of Fast Track Initiative Inc, founded in 2004, serving as CEO and Managing Partner.
Current jobs include Executive Director & Chief Scientific Officer at The Children's Mercy Hospital; President, Representative Director & Partner at Life Science Management, Inc. since 2000; Director at AccuRna, Inc., HanaVax, Inc., and NeoPhore Ltd.; Outside Director at Braizon Therapeutics, Inc.; and Investment Director at Astellas Venture Management LLC since 2018.
Former jobs include Associate Director & Head-Research at Millennium Pharmaceuticals, Inc. from 2013 to 2014; Associate Director & Research head at Takeda Pharmaceutical Co., Ltd. from 2007 to 2014; President & Representative Director at HuBit Genomix KK; Senior Director at Astellas Pharma, Inc. from 2014 to 2018; President & Representative Director at Monsanto Japan Ltd.; Director at CellSeed, Inc. from 2001 to 2011; and Director at CYTLIMIC, Inc. Education includes graduate and doctorate degrees from the University of Tokyo and an MBA from Stanford University.